1. "2002"
Formats
  1. Journal Article (1317)
  2. Meeting Abstract (466)
  3. Book Section (119)
  4. Conference Paper (20)
  5. Book Whole (11)
Groups
  1. Department of Medicine (502)
  2. Sloan Kettering Institute Faculty (455)
  3. Surgery (405)
  4. GSK Faculty (387)
  5. Molecular Pharmacology and Chemistry Program Faculty (275)
  6. Solid Tumor Oncology Division (259)

More Groups

People
  1. Murray Brennan (60)
  2. David Klimstra (49)
  3. Ashok Shaha (48)
  4. Klaus Busam (38)
  5. Carlos Cordon-Cardo (36)
  6. Howard Scher (35)

More People

Years
  1. 2002 (1933)
Publications
  1. Blood (100)
  2. Proceedings of the American Association for Cancer Research Annual Meeting (59)
  3. Journal of Clinical Oncology (57)
  4. Modern Pathology (46)
  5. Laboratory Investigation (43)
  6. Annals of Surgical Oncology (37)

More Publications

Publishers
  1. Elsevier Inc. (180)
  2. American Association for Cancer Research (122)
  3. Lippincott Williams & Wilkins (116)
  4. Nature Publishing Group (110)
  5. Elsevier Science, Inc. (106)
  6. American Society of Hematology (100)

More Publishers

Results (1933)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Role of Id proteins in tumor angiogenesis
    Meeting Abstract

    Mittal, V.; Schoer, R.; Ruzinova, M.; Benezra, R.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • Measuring response to therapy with molecular imaging
    Meeting Abstract

    Larson, S. M.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • Inhibition of activated DNA transcription by Ecteinascidin 743 (ET-743)
    Meeting Abstract

    Kolb, E. A.; Hu, Z.; Friedman, D.; Scotto, K.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • A phase I clinical trial of an oral formulation of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)
    Meeting Abstract

    Kelly, W.; O'connor, O.; Richon, V. M.; Tong, W.; Rao, T. D.; Chiao, J.; O'Brien, J. P.; Rifkind, R. A.; Marks, P. A.; Scher, H. I.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • Phase 2 study of TLK286 (GST P1-1 Activated Glutathione Analog) in patients with platinum and paclitaxel refractory/resistant advanced epithelial ovarian cancer
    Meeting Abstract

    Kavanagh, J. J.; Kudelka, A.; Spriggs, D. R.; Bookman, M. A.; Lewis, L.; Maack, C.; Dombroski, J.; Macpherson, J.; Henner, W. D.; Brown, G. L.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • A phase I study of the novel high affinity VEGF blocker VEGF trap in patients with refractory solid tumors and lymphoma
    Meeting Abstract

    Dupont, J.; Pezzulli, S.; Gordon, M.; Mendelson, D.; Murren, J.; Hsu, A.; Holash, J.; Stahl, N.; Cedarbaum, J.; Spriggs, D. R.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • 17AAG low target binding affinity and potent whole cell potency: Finding an explanation
    Meeting Abstract

    Chiosis, G.; Huezo, H.; Rosen, N.; Mimnaugh, E.; Neckers, L.; Whitesell, L.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • Phase I and pharmacokinetic study of LY293111, an orally available small molecule known to be an LTB4 receptor antagonist, 5-lipoxygenase inhibitor and peroxisome proliferator activated receptor-gamma agonist (PPAR gamma)
    Meeting Abstract

    Budman, D. R.; Schwartz, G. K.; Endres, S.; Welch, M.; O'reilly, E.; Barile-Thiem, B.; Brail, L. H.; De Alwis, D. P.; Cleverly, A.; Weitzman, A.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • Molecular imaging of endogenous gene expression
    Meeting Abstract

    Blasberg, R.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • A phase I/II study of DX-8951f and gemcitabine in advanced solid tumour malignancies
    Meeting Abstract

    Abou-Alfa, G.; Lenzi, R.; Mani, S.; Schwartz, G.; Maki, R.; Kelsen, D.; Levin, A.; Ackerman, J.; DeJager, R.; O'reilly, E.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save